Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 20, 2026Score 0/30
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.57MP/E –Yield –
Bioxytran free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
No free cash flow figures for Bioxytran
Bioxytran has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?